NEW YORK (GenomeWeb) – GenMark Diagnostics said after the close of the market on Tuesday that revenues for its fourth quarter rose 51 percent year over year. 

The Carlsbad, Calif.-based company posted revenues of $9.8 million for the three months ended Dec. 31, 2014, up from $6.5 million in the year-ago quarter, beating the consensus Wall Street estimate of $9.1 million. During the recently completed quarter, GenMark placed 38 XT-8 analyzers in end-user laboratories for a total installed base of 540 instruments in the US as of the end of 2014. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.